Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: J Med Chem. 2012 Feb 16;55(5):2406–2415. doi: 10.1021/jm201690h

Figure 5.

Figure 5

Percentage of radioactivity in plasma represented by unchanged radioligand after injection of a monkey with [18F]9 at baseline, after treatment with 9, and after treatment with ciproxifan. The remainder of radioactivity was composed of radiometabolites [18F]A-C.